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Delayed graft failure, the most frequent type of
prosthetic arterial graft failure, accounts for the
majority of disease attributable to prosthetic grafts.
Smooth muscle cell proliferation, migration, and
extracellular matrix deposition that results in anasto-
motic intimal hyperplasia remain the most important
causes of delayed graft failure.1-5 In most animal
models, hyperplasia appears to be present at all anas-
tomoses but is quantitatively greater at the distal
anastomosis.6-8 We have used a canine prosthetic
arterial graft model to study graft healing.
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Purpose: Anastomotic intimal hyperplasia remains a significant cause of delayed pros-
thetic arterial graft failure. Prior studies have identified several genes with altered
expression within the hyperplastic region at the downstream polytetrafluoroethylene
arterial anastomosis as compared with normal arteries. The purpose of the current study
was to determine the sequence of early gene-related events at the distal anastomosis of
an in vivo prosthetic arterial graft model. Messenger RNA (mRNA) differential display
was used to screen for alterations in gene expression between anastomotic sites and con-
trol arterial segments.
Methods: Six carotid interposition 6-mm expanded polytetrafluoroethylene grafts were
placed in mongrel dogs, with the intervening carotid artery segment serving as the base-
line control. Five days after graft implantation, the distal anastomotic artery segments
were harvested and total RNA was isolated from both the intervening normal arteries
and anastomotic segments. Differential mRNA display was used to identify candidate
complementary DNA (cDNA) clones with expression that differed in anastomotic seg-
ments as compared with normal intervening arteries. Northern blot analysis confirmed
alteration of gene expression. The cDNA clones were sequenced, and gene databases
were searched. Novel sequences were used as probes for screening human cDNA
libraries.
Results: Approximately 7000 mRNA species were screened, and 26 candidate clones were
obtained. Northern blot analysis showed altered gene expression in 10 (38%) of the
clones, undetectable signals in 13 (50%), and nonregulation in 3 (12%). Seven clones
with 92% homology at the nucleotide level to human a 1 (III) procollagen gene and a
novel sequence were expressed only at the distal anastomosis. A clone representing
apolipoprotein J and a novel sequence had increased expression at the distal anastomo-
sis of 364% ± 236% and 156% ± 47%, respectively (mean percentage, control ± standard
deviation).
Conclusions: These studies identified genes with expressions that increased or were exclu-
sive to the distal anastomosis of healing prosthetic arterial grafts in an in vivo prosthet-
ic arterial graft model. Type III collagen may contribute significantly to the composition
of the extracellular matrix associated with intimal hyperplasia by increasing lesion vol-
ume. Apolipoprotein J, through its association with proteases, may modulate some of
the matrix changes seen early after grafting. (J Vasc Surg 1998;28:157-66.)
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Dogs lack spontaneous endothelialization of
prosthetic grafts (standard 60- m m internodal distance
polytetrafluoroethylene [PTFE]). Pannus growth
extends approximately 1 cm into the graft from each
anastomosis, and the central portion is composed of
acellular compact fibrin (pseudointima).9-10 This
healing characteristic is similar to that of humans. In
contrast, the prosthetic flow surface in nonhuman
primates heals with a cellular neointima by both pan-
nus extension and transinterstitial growth.11
Many cytokines—including platelet-derived
growth factor, basic fibroblast growth factor, and
transforming growth factor beta (TGF- b )—have
been implicated in the development of the local-
ized hyperplastic lesion.12-14 Yet, the sequence of
molecular events and their temporal relation that
leads to intimal hyperplasia after prosthetic grafting
are not fully understood. The technique of differ-
ential display has been used to screen for altered
gene expression between anastomotic regions and
normal arteries.15-17 We previously have identified
several genes with altered expression within the
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Fig. 1. Carotid interposition prosthetic graft model. Intervening normal artery and distal
anastomotic artery segments from three separate animals were used in differential display study.
hyperplastic region at the downstream PTFE arter-
ial anastomosis late after grafting. The purpose of
the current study was to determine the sequence of
gene-related events at the distal anastomosis of an
in vivo prosthetic arterial graft model early after
graft implantation.
MATERIALS AND METHODS
Mongrel dogs that weighed 20 to 25 kg were
used in this study. Animal care complied with the
guidelines from the National Society for Medical
Research and the National Institutes for Health.18
Expanded PTFE grafts and suture materials were
obtained from W. L. Gore & Associates, Inc.
(Elkton, Md.). Enzymes were purchased from Gibco
(Bethesda, Md.), unless indicated otherwise.
Phosphorus 32-labeled deoxyadenosine triphosphate
(dATP) and sulfur 35-labeled dATP were obtained
from Dupont/New England Nuclear (Wilmington,
Del.). Polymerase chain reactions (PCR) were per-
formed in Costar 96-well polycarbonate plates in a
Hybaid Omnigene thermocycler with AmpliTaq
DNA polymerase and 10 · PCR buffer (Costar,
Cambridge, Mass.). PCR primers were obtained
from Operon Technologies, Inc. (Alameda, Calif.).
Graft placement and harvest. A midline neck
incision was made with the dogs under general anes-
thesia, and both carotid arteries were dissected free,
which yielded a segment approximately 15 to 20 cm
in length. After heparinization (100 U/kg), the
intervening carotid artery was excised and immedi-
ately snap frozen in liquid nitrogen. The artery
served as a baseline control. Standard end-to-end
anastomoses were constructed with 6-mm (internal
diameter) expanded PTFE grafts and 6-0 PTFE
suture (Fig. 1). Patency of the grafts was established
by palpation and Doppler examination. At 5 days
after graft implantation, the 2-cm distal anastomotic
segment was excised, and the animal was killed. All
grafts were patent at the time of anastomotic har-
vest. A small portion of the distal anastomosis was
retained for histologic analysis; the majority was
immediately frozen in liquid nitrogen and stored at
–80° C before total RNA isolation. The distal artery
segment consisted of all layers of the vessel wall and
any tissue that extended into the graft lumen.
Differential display. Differential display was per-
formed as previously described.15-17 Total RNA was
extracted independently from the distal anastomotic
artery segment and intervening normal arteries from
each animal with Ultraspec RNA solution (Biotecx
Laboratories Inc., Houston, Tex.). Deox-
yribonuclease was added to 25 m g of RNA in the pres-
ence of pancreatic ribonuclease inhibitor in 1· PCR
buffer and incubated at 37° C for 30 minutes to
remove any DNA contaminant. Phenolchloroform
extraction was performed before ethanol precipita-
tion. Two reverse transcription (RT) reactions were
performed for each RNA sample with 0.2 m g of
DNA-free total RNA in 1· RT buffer, 10 mmol/L
dithiothreitol, 20 m m each of deoxyguanosine
triphosphate, dATP, deoxycytosine triphosphate, and
deoxythymidine triphosphate, and 1 m m of either
T12XC or T12XG, where X is threefold degenerate for
guanine, adenine, and cystosine.17 The solution was
heated to 65° C for 5 minutes and cooled to 37° C
for 10 minutes before the addition of 200 units of
reverse transcriptase. After incubation at 37° C for 1
hour, the mixture was heated to 95° C for 5 minutes
before storage at 4° C. PCR was performed in 96-well
polycarbonate plates. Reaction mixtures contained
0.1 ml volume of reverse transcription reaction, 1 ·
PCR buffer, 4 m mol/L of deoxyguanosine triphos-
phate, deoxythymidine triphosphate, deoxycytosine
triphosphate, and 2 m m dATP, 370 m Ci sulfur 35-
labeled dATP, 1 m mol/L of the respective T12XN (X
= G, A, or C; N = G or C), 0.2 m mol/L of specific
arbitrary 10 base pair (bp) primer, and 10 units of
AmpliTaq DNA polymerase. Light mineral oil
(Sigma, St. Louis, Mo.) was overlaid, and the follow-
ing PCR reactions were performed: 1 cycle of 95° C
for 1 minute; 40 cycles of 94° C for 45 seconds, 40°
C for 90 seconds, and 72° C for 30 seconds (incre-
mented 2 seconds per cycle); and 1 cycle of 72° C for
15 minutes. DNA sequencing stop buffer (U. S.
Biochemical Corp., Cleveland, Ohio) was added to
each sample and heated to 80° C for 2 minutes before
loading on 6% polyacrylamide sequencing gel. A
number of arbitrary 10 base pair sequences were
screened against T12XC and T12XG RT products
from both distal anastomotic and normal artery seg-
ments with differential display. Identical reactions
with use of separate RT reaction products were run
side by side on the gel for confirmation. Gels were run
at 65 W constant current, dried without fixation, and
exposed directly to Kodak XAR-5 film (Eastman
Kodak Co., Rochester, N.Y.) for 48 hours at room
temperature.
Band recovery. Bands that showed repro-
ducible differences in two separate RT/PCR reac-
tions were excised under sterile conditions. The
dried gel slice was placed in 10 mmol/L tris/HCl/1
mmol/L ethylenediamine tetraacetic acid and boiled
for 30 minutes before rapid cooling to 4° C. The
supernatant was removed, and ethanol was precipi-
tated in the presence of glycogen. The pellet was
resuspended in sterile water after a 95% ethyl alcohol
(volume per volume) wash. Reamplification by PCR
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was performed with the appropriate primers, and
conditions were noted except for deoxyribonucleo-
side triphosphate concentrations of 25 m m and no
radioisotope. After visualization with ethidium bro-
mide, DNA was excised from 2% agarose gels and
eluted with use of polyethylene spin columns.20 The
eluent was used directly for subcloning and subse-
quent probe generation.
Subcloning. The TA Cloning Kit-Version D
(Invitrogen, San Diego, Calif.) was used for all sub-
cloning reactions. Ligation products were trans-
formed into competent Escherichia coli and plated
for kanamycin resistance. White colonies were select-
ed, and the alkaline lysis minipreparation was used
for isolation of plasmids.23 The presence of an insert
was confirmed by ethidium bromide staining after
restriction enzyme digestion and 2% agarose gel
electrophoresis. The plasmids were used for DNA
sequencing.
Northern blot analysis. Radioactive probes
were generated with Amersham Multiprime labeling
kits (Amersham Corp., Arlington Heights, Ill.) and
phosphorus 32-labeled dATP. Northern blot analy-
sis was performed with use of formaldehyde dena-
turing gel electrophoresis, Biotrans nylon mem-
branes (ICN Biochemicals, Irvine, Calif.),21 and
ultraviolet crosslinking by use of a Fischer Scientific
UV Crosslinker (FB-UVXL-1000, Fischer Scientific,
Houston, Tex.). Blots were prehybridized for 30
minutes and hybridized (1 · 106 cpm/ml) for 2
hours at 68° C with Stratagene Quick-Hyb Solution
(Stratagene, La Jolla, Calif.) and salmon sperm DNA
(10 mg/ml). Blots were washed in 0.5 SSC (NaCl,
NaCit) and 5% sodium dodecyl sulfate at 68° C with
four changes for 1 hour. Signals were analyzed with
use of a PhosphorImager (Molecular Dynamics,
Sunnyvale, Calif.). Lane-loading differences were
normalized with 36 B4 complementary DNA
(cDNA) probe.15,16,22
Immunohistocytochemistr y. Immuno-
histocytochemistry protocols were performed with
type III collagen antibodies obtained from Biodesign
International (Kennebunk, Me.). Sections were
adhered to poly-L-lysine–coated slides, deparaffinized,
hydrated, and incubated with primary antibody for 1
hour. After incubation with primary antibody, sections
were rinsed in Tris-buffered saline solution containing
2% goat serum. Species-appropriate biotinylated sec-
ondary antibody was applied followed by avidin-biotin
peroxidase complexes (ABC Elite Kits, Vector
Laboratories, Inc., Burlingame, Calif.). Antibody pres-
ence was identified with 3-amino-9-ethylcarbazole and
counter-stained with Gills hematoxylin. Omission of
primary antibody served as the negative control.
Sequencing. Automated direct sequencing of
the inserts was performed with use of M13 forward,
M13 reverse, T7 and T3 primers, and an ABI 373A
DNA sequencer by the Biopolymers Facilities at
Harvard Medical School and the Molecular Core
Facility at Dana Farber Cancer Center. Gene data-
base searches were performed through the National
Center for Biotechnology Information with use of
the BLAST network service.24,25 The GenBank and
European Molecular Biology Laboratory searches
revealed that seven of the clones with altered expres-
sion were homologous to one gene and that three
sequences had no homology with known genes.
These three sequences, designated 2C3, 2C4, and
2C5, were 558 bp, 402 bp, and 371 bp in length,
respectively, and were used as probes to screen
human cDNA libraries.
Isolation and characterization of cDNA clones.
The human heart and human brain (hippocampus)
cDNA libraries in l ZAPII vector (Catalog Nos.
93625 and 936207, Stratagene) were screened (~5 ·
105 recombinants/screening) with the three novel
sequences obtained from the differential display gels.
The sequences were labeled with a -phosphorus 32-
labeled dATP with random-primed cDNA labeling.
Hybridization to nylon membranes was performed in
50% formamide, 6 · SSC, 10 mmol/L sodium phos-
phate, 5 · Denhardt’s solution, 0.1% sodium dodecyl
sulfate (SDS), and 1 mg/ml salmon sperm DNA
(Gibco) at 42° C overnight. The filters were washed
in 2 · SSC and 1% SDS at room temperature for 30
minutes, then 2 · SSC and 0.1% SDS at 42° C for 30
minutes, and finally with 0.2 · SSC and 0.1% SDS at
63° C for 30 minutes. The membranes were
crosslinked with a Fischer Scientific (Houston, Tex.)
UV Crosslinker. Six clones were isolated from the hip-
pocampus library and processed. These six clones
were identified with the 2C3 and 2C4 probes. No
clones were identified with the 2C5 probe from either
cDNA library.
Expression of 2C3 and 2C5 in human adult
tissues. The expression of the 2C3 and 2C5 novel
clones was characterized by probing multiple tissue
blots (human RNA tissue). Expression in human
adult tissues was assessed by hybridization of the
cDNA probe to a Northern blot of poly (A+) RNA
from human heart, brain, placenta, lung, liver, skele-
tal muscle, kidney, and pancreas (CLONTECH,
Palo Alto, Calif.). The same blot was hybridized
with b -actin as a lane-loading control.
RESULTS
A total of 24 arbitrary 10 base pair sequence
primers were screened against T12XC and T12XG
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with each differential display lane yielding approxi-
mately 200 discrete bands. Approximately 7000
RNA species were evaluated, which represented 35%
to 70%15 of the estimated 10,000 to 20,000 cellular
genes expressed at any given time.26 Only banding
differences that were confirmed by two separate
RT/PCR reactions were chosen for further evalua-
tion. Analysis of the differential display gels revealed
26 candidate clones that appeared to have increased
expression in the distal anastomotic artery segment.
All sequenced clones were 240 to 560 bp in length
and exhibited characteristics of the 3’ end of eukary-
otic mRNA with flanking sites complementary to
the PCR primers.
Northern blot analysis was performed with phos-
phorus 32-labeled DNA from the clones recovered
from the differential display gels. With total RNA,
altered expression was seen with 10 clones (38%),
nonregulation with 3 clones (12%), and signals were
not detectable with 13 clones (50%), presumably
because of low messenger levels. The 10 clones with
confirmed altered expression were sequenced, and
gene databases were searched for homology to
known genes. These clones constituted 4 distinct
genes, including 3 novel nucleotide sequences.
Seven clones were identical and had 92% homology
at the nucleotide level to human a 1 (III) procolla-
gen gene.27-29 One novel sequence and the clone
with homology to human a 1 (III) procollagen gene
were expressed only at the distal anastomotic artery
segment (Fig. 2). The cDNA sequence of the clones
with homology to human a 1 (III) procollagen gene
is characterized by the flanking primer sequences
that were used in the differential display, and its
apparent mRNA size is consistent with previous
sequence data.30 In addition, two novel sequences
had increased expression at the distal anastomosis of
364% ± 236% and 156% ± 47% (mean percentage,
control ± standard deviation).
Immunohistocytochemistry with an antibody to
type III collagen performed on the 5-day anasto-
motic artery segment showed an increased signal in
the developing pseudointima (Fig. 3).
The three novel sequences identified and desig-
nated as 2C3, 2C4, and 2C5 were used as probes to
screen the human heart and hippocampus cDNA
libraries. Three independent clones were identified
and isolated from the hippocampus library, and each
of the probes was termed 2C3 (558 bp) and 2C4
(471 bp). No clones were identified in either cDNA
library with the 2C5 probe (371 bp). The cDNA
clones obtained had inserts of approximately 1.5
kilobase (kb) to 2.5 kb. The six clones obtained were
processed and isolated with the Exassist helper phage
and XLOLR system (Statagene, La Jolla, Calif.) and
were sequenced on both strands. Sequence data
analysis of the 2C4 clones has identified the gene
apolipoprotein J (apo J). Preliminary isolation and
characterization of the clones isolated with the 2C3
probe have not yet identified a distinct gene.
The expression of the novel 2C3 and 2C5 clones
was characterized by Northern blot analysis of heart,
brain, placenta, lung, liver, skeletal muscle, kidney,
and pancreatic adult tissues. Northern blot analysis
with the 2C5 probe revealed a single mRNA of 3.5
kb in heart, skeletal muscle, and pancreas tissues
(Fig. 4). The expression of the 2C5 clone was high-
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Fig. 2. Differential mRNA display and Northern blot
analysis of two cDNA fragments that are expressed only at
the distal anastomosis of our model. A, Differential display
(top) and Northern blot analysis (bottom) of a cDNA frag-
ment with sequence homology to a 1 (III) collagen. B,
Differential display (top) and Northern blot analysis (bot-
tom) of a novel cDNA fragment. Northern blot analysis
was performed with 20 µg of total RNA per lane from
normal artery (C) and anastomotic artery segment (A) of
three separate animals. The same blots were reprobed with
36B4 as a lane-loading control. Relative positions of 28S
and 18S ribosomal RNA are indicated.
est in the pancreas and skeletal muscle, with weak
expression seen in the heart tissue. Northern blot
analysis with the 2C3 probe revealed a 2.0 kb
mRNA strongly expressed in heart, brain, and pan-
creatic tissue and weakly expressed in lung tissue
(Fig. 4). The same mutiple tissue blot was hybrid-
ized with b -actin as a control for uniform lane-
loading (not shown).
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Fig. 3. Immunohistocytochemistry of distal anastomotic artery segment performed with anti-
body to type III collagen. The PTFE graft is seen on the left, and the native vessel is on the
right. Moderate staining (copper) is seen in the media of the vessel, and significantly enhanced
staining is seen in the developing pseudointima (arrow).
Fig. 4. Expression of 2C3 and 2C5 clones in human adult tissues. A, Northern blot analysis
of 2C3 cDNA clone in human adult tissues. B, Northern blot analysis of 2C5 cDNA clone in
human adult tissues. The RNA blot was hybridized with 32P-labeled 2C3 and 2C5 probes fol-
lowed by hybridization with b -actin as a lane-loading control.
DISCUSSION
Anastomotic intimal hyperplasia remains the
major cause of prosthetic arterial graft failure. The
development of the hyperplastic lesion involves
smooth muscle cell proliferation and migration with
deposition of extracellular matrix (ECM).31 The
arterial wall response to injury is characterized by a
burst of medial smooth muscle cell proliferation that
peaks at 48 hours and is followed by smooth muscle
cell migration into the intima 3 to 5 days after
injury.32-34 Many growth factors, including platelet-
derived growth factor, basic fibroblast growth factor,
and TGF-b , have been implicated as possible smooth
muscle cell mitogens in the response of the vascular
wall to injury. Yet, the molecular events that lead to
the development of the hyperplastic lesion after
prosthetic arterial grafting are not fully understood.
We used a canine graft model to study the early
gene-related changes associated with graft healing.
The healing characteristic of canines is similar to that
of humans; both lack spontaneous endothelializa-
tion of prosthetic grafts (standard 60 m m internodal
distance PTFE).9-11 The technique of differential
display was used to screen for possible differences in
gene expression between the normal artery and the
distal anastomotic segment. Intimal hyperplasia
occurs at both anastomoses but is most clinically rel-
evant at the distal anastomotic segment. Future
studies will analyze gene expression in the proximal
anastomotic artery segments. The method involves
the reverse transcription and amplification of
mRNAs. The amplified cDNA subpopulations of 3’
termini of mRNAs are then resolved on a sequenc-
ing gel. In this study, we evaluated approximately
7000 RNA species, which represent 35% to 70% of
the estimated cellular genes expressed at any given
time. We selected 26 candidate clones that appeared
to have increased expression in the distal anastomot-
ic artery segment. No candidate clones were found
with decreased expression in this time period of our
study. Northern blot analysis confirmed altered
expression in 10 of these clones. Seven clones were
identical and had 92% homology at the nucleotide
level to human a 1 (III) procollagen gene.27-29 One
novel sequence and the clones with homology to a 1
(III) procollagen were expressed only at the distal
anastomosis of three separate animals (Fig. 2). In
addition, two novel sequences had increased expres-
sion at the distal anastomosis of 364% ± 236% and
156% ± 47% (mean percentage, control ± standard
deviation). The novel sequences isolated were subse-
quently used as probes to screen human cDNA
libraries. The current availability of canine cDNA
libraries is limited, but significant homology (>70%
homology at the nucleotide level) is often preserved
in genes between species. Six clones were identified
and isolated with two of the novel sequences.
Independent clones isolated with the novel sequence
2C4 had significant homology to apo J.
Smooth muscle cell proliferation accounts for the
initial increase in intimal volume, but approximately
4 weeks after injury smooth muscle cell growth stops,
and extracellular matrix production predominates.35
The major components of the extracellular matrix
associated with the formation of a neointima are pro-
teoglycans, elastin, and collagen types I and III.36
There are distinct distributions of type I and type III
collagen in normal vessels, atherosclerotic plaques,
and areas of diffuse intimal thickening. In studies
with normal and atherosclerotic human aorta,
McCullagh et al.37 found that type III collagen is the
predominant collagen species in normal aortic media
and in areas of diffuse intimal thickening; type I col-
lagen is abundant in atherosclerotic plaques. In our
model, we found that the expression of type III col-
lagen mRNA is prominent in the distal anastomotic
artery segment 5 days after graft implantation.
Protein expression as measured by immunohistocyto-
chemistry also appears to be increased in the devel-
oping pseudointima. No expression of type III colla-
gen mRNA was noted in the intervening normal
artery of the same animals. In an angioplasty model,
Choi et al.38 found a significant increase (9.3-fold) in
the mRNA expression of type I collagen within 2
days after injury and a less prominent increase (three-
fold) in type III collagen 2 weeks after injury.
Interestingly, Liau and Chan39 have found that a 1
(III) collagen mRNA levels exhibit an inverse rela-
tionship with vascular smooth muscle cell prolifera-
tion in vitro and cellular quiescence is coupled closely
to increases in type III collagen mRNA levels. They
found that a fivefold increase in density in mRNA lev-
els for a 1 (III) collagen arrested vascular smooth mus-
cle cells. In addition, Stepp et al.40 have observed that
collagen production by smooth muscle cells increased
significantly as the cells approached confluence and
collagen mRNA levels peaked earlier when cells were
seeded at higher densities. The exact role of a 1 (III)
collagen is unknown, but the collagen is abundant in
tissues that are rich in smooth muscle cells27 and may
contribute significantly to the composition of the
extracellular matrix associated with intimal hyperpla-
sia. Intimal hyperplasia results from the migration and
proliferation of medial smooth muscle cells, so one
might expect type III collagen, which is abundant in
the normal media, to be a significant contributor to
the ECM that is associated with hyperplasia. Clowes
and Schwartz41 have shown that approximately 50%
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of vascular smooth muscle cells that migrate across
the internal elastic lamina are nondividing cells.
Quiescent smooth muscle cells in the intima may con-
tribute to the increase in a 1 (III) collagen seen early
after graft implantation in our model. In addition,
TGFb is known to stimulate the production of colla-
gen,42 and Majesky et al.43 have shown that collagen
a 1 (III) transcripts are increased during neointima
formation and at sites where TGF-b 1 immunostaining
is present. Hence, the increase in expression of a 1
(III) collagen at the distal anstomosis early after graft
implantation may be partly a result of smooth muscle
cell stimulation by TGF-b .
Apo J is a glycoprotein that is associated with
high-density lipoproteins.44 Apo J mRNA, unlike
other human apolipoproteins, is present in relatively
high levels in liver, brain, and testis tissues and is less
abundant in heart, spleen, or breast tissues.45 In our
model, the expression of a clone with strong homol-
ogy to apo J was significantly increased in the distal
anastomotic artery segment when compared with
normal arteries. Apo J expression has been shown to
increase during prostate involution,46 neurodegener-
ation,47 and transplant-associated arteriosclerosis.48
The function of apo J is unknown, but increasing evi-
dence shows that apo J may be involved in tissue
remodeling. Brow et al.49 found that apo J induction
in the uterus correlated with the tissue reorganiza-
tion caused by declining progesterone levels.
Swertfeger et al.,50 with models of myocarditis and
ventricular hypertrophy, have shown a correlation
between apo J induction and ventricular tissue dam-
age but not hypertrophy, which suggests that it may
function as a repair response protein. In addition,
apo J can bind proteases,51 carboxyesterases,52 and
fibronectin53 and may play an important role in the
matrix changes associated with the development of
the neointimal lesion. Further work is ongoing to
generate the protein coded by our clone and to study
its role in the development of the hyperplastic lesion.
Expression of the two novel sequences was
observed in adult human tissues. Interspecies homol-
ogy at the nucleotide level allows for cross-hybridiza-
tion. The clone 2C3 was expressed in all the adult tis-
sues that were analyzed, with the strongest expression
in the heart, brain, and pancreatic tissues. In contrast,
expression of 2C5 was seen only in the heart, skeletal
muscle, and pancreatic tissue. Preliminary isolation
and characterization of clones isolated from a human
brain cDNA library with the 2C3 sequence has not
yet identified a distinct gene. Further effort will be
required to isolate the full-length cDNA copies of
these two novel sequences.
In summary, we have identified four distinct
genes that have altered expression at the distal anas-
tomosis of an in vivo prosthetic arterial graft model 5
days after graft implantation. The extracellular matrix
gene a 1 (III) collagen is expressed only in the distal
anastomosis of our prosthetic arterial graft model.
Type III collagen, which is abundant in the normal
media, may contribute significantly to the ECM that
is associated with neoimtima. Apo J, an appparent
repair response protein, may modulate some of the
matrix changes that are associated with the migration
of smooth muscle cells across the internal elastic lam-
ina. The analysis of the gene-related events at the dis-
tal anastomosis of a prosthetic arterial graft at differ-
ent time points after implantation may help to eluci-
date the mechanisms involved in the arterial response
to injury and provide therapeutic windows for possi-
ble drug or antisense therapies.
The authors gratefully acknowledge Roanna London
for indispensable assistance with the cDNA library screen-
ing. The novel nucleotide sequence data reported in this
paper has been deposited in the GenBank database and is
available under accession numbers U63896/U63897.
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